Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Duolingo, Inc.DUOL · Entity 3679 | Director | October 10, 2026 | October 14, 2026 |
| Khosla Ventures Acquisition Co.KVSA · Entity 141683 | Director | March 03, 2021 | March 03, 2021 |
| Oscar Health, Inc.OSCR · Entity 3582 | Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Duolingo, Inc.
Report date October 10, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 4,378 |
Reported balance
After 2026-10-10 transaction · row 1
1 source rowRow 1 · 2026-10-10 · Grant · Acquired 116 · Balance 4,378 F1: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan.
Khosla Ventures Acquisition Co.
Report date March 03, 2021 · Filed March 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-03-03 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the completion of the Issuer's initial business combination, subject to adjustment as set forth in the Amended and Restated Certificate of Incorporation of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the completion of the Issuer's initial business combination, subject to adjustment as set forth in the Amended and Restated Certificate of Incorporation of the Issuer.
Oscar Health, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 449,444 |
Reported balance
After 2026-09-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-03 · Sale · Disposed 31,422 · Balance 449,444 F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2026 Filed Jan 8, 2026 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 76,962 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000004 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 427,142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 86,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000002 · primarydocument.xml · derivative · entry 6 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,532,293 Underlying: Class A Common Stock · 86,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 96,928 | $15.64 | $1,515,953.92 |
DisclosureSEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 4 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350,180 F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.42 to $15.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 86,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 447,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 59,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000002 · primarydocument.xml · derivative · entry 5 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,619,186 Underlying: Class A Common Stock · 59,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 137,933 | $15.02 | $2,071,753.66 |
DisclosureSEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 360,215 F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 59,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 498,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| December 24, 2025 Filed Dec 30, 2025 21:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 38,835 | $15.00 | $582,525.00 |
DisclosureSEC source: 0001844320-25-000012 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 438,348 F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 23,965 | $16.59 | $397,579.35 |
DisclosureSEC source: 0001844320-25-000010 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 477,183 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 105,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 10 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,678,986 Underlying: Class A Common Stock · 105,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass B Common Stock · Derivative | 141,330 | $6.36 | $898,858.80 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 9 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,784,286 Underlying: Class A Common Stock · 141,330 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionStock Option (Right to Buy) · Derivative | 141,330 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 8 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 141,330 shares Expires 2025-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 7, 2025. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 105,300 | $15.05 | $1,584,765.00 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 4 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,148 F2 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported herein. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.83 to $15.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 105,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 606,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 286,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 7 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,642,956 Underlying: Class A Common Stock · 286,182 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass B Common Stock · Derivative | 413,835 | $6.36 | $2,631,990.60 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 6 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,929,138 Underlying: Class A Common Stock · 413,835 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionStock Option (Right to Buy) · Derivative | 413,835 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 5 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,330 Underlying: Class B Common Stock · 413,835 shares Expires 2025-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 7, 2025. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 286,182 | $15.27 | $4,369,999.14 |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,148 F2 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported herein. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 286,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 787,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:20 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 395,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-25-000005 · primarydocument.xml · derivative · entry 5 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,515,303 Underlying: Class A Common Stock · 395,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:20 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass B Common Stock · Derivative | 555,165 | $6.36 | $3,530,849.40 |
DisclosureSEC source: 0001844320-25-000005 · primarydocument.xml · derivative · entry 4 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,910,303 Underlying: Class A Common Stock · 555,165 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:20 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionStock Option (Right to Buy) · Derivative | 555,165 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001844320-25-000005 · primarydocument.xml · derivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 555,165 Underlying: Class B Common Stock · 555,165 shares Expires 2025-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 7, 2025. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:20 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 395,000 | $18.43 | $7,279,850.00 |
DisclosureSEC source: 0001844320-25-000005 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,148 F2 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported herein. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:20 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 395,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-25-000005 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 896,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Tax withholdingClass A Common Stock | 23,879 | $16.66 | $397,824.14 |
DisclosureSEC source: 0001844320-25-000003 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,148 F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs"). F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 11, 2025 Filed Jun 20, 2025 12:01 UTC | Duolingo, Inc. DUOL · Entity 3679 | GrantClass A Common Stock | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0001562088-25-000150 · wk-form4_1750420870.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Issuer's Class A Common Stock for each RSU upon vesting. 100% of the RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Tax withholdingClass A Common Stock | 23,879 | $13.80 | $329,530.20 |
DisclosureSEC source: 0001562180-25-004436 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,027 F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs"). F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Also includes 172,940 shares to be issued upon vesting of RSUs that due to clerical error were not included in this total in the Reporting Person's Form 4 filed on March 4, 2025. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:51 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 172,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002215 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,966 F1 · shares: The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2025, subject to the reporting person's continuous service through each vesting date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:54 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Tax withholdingClass A Common Stock | 7,970 | $14.61 | $116,441.70 |
DisclosureSEC source: 0001562180-25-001992 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,697 F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs"). F2 · balance_after: Includes 115,294 shares to be issued upon vesting of RSUs previously reported in Table II. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 117 | $18.48 | $2,162.16 |
DisclosureSEC source: 0001562180-24-008103 · primarydocument.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,962 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 6,399 | $18.07 | $115,629.93 |
DisclosureSEC source: 0001562180-24-008103 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,079 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 21:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Unit · Derivative | 14,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-008103 · primarydocument.xml · derivative · entry 4 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,705 Underlying: Class A Common Stock · 14,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F5 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 21:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 14,412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-008103 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 00:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 1,311 | $17.85 | $23,401.35 |
DisclosureSEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 4 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,066 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 00:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 1,605 | $17.46 | $28,023.30 |
DisclosureSEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,377 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 3,198 | $17.99 | $57,532.02 |
DisclosureSEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,982 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Unit · Derivative | 14,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006662 · primarydocument.xml · derivative · entry 5 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,117 Underlying: Class A Common Stock · 14,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F6 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F6 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 14,412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| July 01, 2024 Filed Jul 4, 2024 00:40 UTC | Duolingo, Inc. DUOL · Entity 3679 | GrantRestricted Stock Units | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001562088-24-000189 · wk-form4_1720053593.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,742 F1 · shares: Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Issuer's Class A Common Stock for each RSU upon vesting. 1/3rd of the RSUs shall vest on each anniversary of July 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the RSUs will be fully vested on the third anniversary of the Vesting Commencement Date. Read SEC document |
| June 04, 2024 Filed Jun 4, 2024 22:05 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 152 | $19.09 | $2,901.68 |
DisclosureSEC source: 0001562180-24-004664 · primarydocument.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,768 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 22:05 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 5,808 | $19.46 | $113,023.68 |
DisclosureSEC source: 0001562180-24-004664 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,920 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 22:05 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Unit · Derivative | 14,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004664 · primarydocument.xml · derivative · entry 4 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,529 Underlying: Class A Common Stock · 14,411 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F5 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 22:05 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 14,411 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-004664 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock · Derivative | 172,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002610 · primarydocument.xml · derivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,940 Underlying: Class A Common Stock · 172,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The Issuer has pulled forward the annual restricted stock unit award that the Reporting Person would otherwise have received for the calendar year 2025 in order to further incentivize and retain the Reporting Person. The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2025. F3 · derivative.expiration_date: The Issuer has pulled forward the annual restricted stock unit award that the Reporting Person would otherwise have received for the calendar year 2025 in order to further incentivize and retain the Reporting Person. The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock · Derivative | 172,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002610 · primarydocument.xml · derivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,940 Underlying: Class A Common Stock · 172,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:28 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 390,405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-007799 · primarydocument.xml · derivative · entry 5 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,355,138 Underlying: Class A Common Stock · 390,405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:28 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass B Common Stock · Derivative | 608,430 | $1.40 | $848,759.85 |
DisclosureSEC source: 0001562180-23-007799 · primarydocument.xml · derivative · entry 4 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,745,543 Underlying: Class A Common Stock · 608,430 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:28 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionStock Option (Right to Buy) · Derivative | 608,430 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001562180-23-007799 · primarydocument.xml · derivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 608,430 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person. F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on January 17, 2024. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:28 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 390,405 | $7.12 | $2,779,019.91 |
DisclosureSEC source: 0001562180-23-007799 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,317 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person. F3 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported above. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.99 to $7.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:28 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 390,405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-007799 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 447,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.